首页 正文

MIER2/PGC1A elicits sunitinib resistance via lipid metabolism in renal cell carcinoma

{{output}}
Introduction: Renal cell carcinoma (RCC) is one of the most common malignant tumors of the urinary system and accounts for more than 90 % of all renal tumors. Resistance to targeted therapy has emerged as a pivotal factor that co... ...